These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24720467)

  • 1. Chemokine receptor 5 (CCR5) delta 32 polymorphism in lupus nephritis: a large case-control study and meta-analysis.
    Cheng FJ; Zhou XJ; Zhao YF; Zhao MH; Zhang H
    Autoimmunity; 2014 Sep; 47(6):383-8. PubMed ID: 24720467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between chemokine receptor 5 Δ32/W gene polymorphism and lupus nephritis.
    Zhou TB; Jiang ZP; Zhou JF; Su N
    Hum Immunol; 2014 Sep; 75(9):968-72. PubMed ID: 25167769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between chemokine receptor 5 delta32 polymorphism and susceptibility to cancer: a meta-analysis.
    Lee YH; Song GG
    J Recept Signal Transduct Res; 2015; 35(6):509-15. PubMed ID: 25203595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine receptor 5 Δ32 polymorphism and systemic lupus erythematosus, vasculitis, and primary Sjogren's syndrome. Meta-analysis of possible associations.
    Lee YH; Kim JH; Song GG
    Z Rheumatol; 2014 Nov; 73(9):848-55. PubMed ID: 24599359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms.
    Sandford B; Bown M; London N; Sayers R
    Int J Immunogenet; 2009 Aug; 36(4):199-205. PubMed ID: 19476483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association of C-C chemokine receptor 5 Δ32 deletion status with rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, and disease severity.
    Martens HA; Gross S; van der Steege G; Brouwer E; Berden JH; de Sevaux R; Derksen RH; Voskuyl AE; Berger SP; Navis GJ; Kallenberg CG; Bijl M
    J Rheumatol; 2010 Nov; 37(11):2226-31. PubMed ID: 20682662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the chemokine receptor 5 delta32 polymorphism and rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC; Song GG
    Mod Rheumatol; 2013 Mar; 23(2):304-10. PubMed ID: 22638733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis.
    Prahalad S
    Genes Immun; 2006 Apr; 7(3):264-8. PubMed ID: 16541097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variations in CC chemokine receptors and hypertension.
    Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
    Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.
    Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S
    Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility.
    Srivastava A; Pandey SN; Choudhuri G; Mittal B
    Scand J Immunol; 2008 May; 67(5):516-22. PubMed ID: 18405329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus.
    Mamtani M; Rovin B; Brey R; Camargo JF; Kulkarni H; Herrera M; Correa P; Holliday S; Anaya JM; Ahuja SK
    Ann Rheum Dis; 2008 Aug; 67(8):1076-83. PubMed ID: 17971457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CCR5-Δ32 heterozygosity on HIV-1 susceptibility: a meta-analysis.
    Liu S; Kong C; Wu J; Ying H; Zhu H
    PLoS One; 2012; 7(4):e35020. PubMed ID: 22496885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility.
    Song GG; Lee YH
    Immunol Invest; 2014; 43(4):299-311. PubMed ID: 24295368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis.
    Brajão de Oliveira K; Reiche EM; Kaminami Morimoto H; Pelegrinelli Fungaro MH; Estevão D; Pontello R; Franco Nasser T; Watanabe MA
    J Cutan Pathol; 2007 Jan; 34(1):27-32. PubMed ID: 17214851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role for CCR5 in murine lupus nephritis.
    Turner JE; Paust HJ; Bennstein SB; Bramke P; Krebs C; Steinmetz OM; Velden J; Haag F; Stahl RA; Panzer U
    Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1503-15. PubMed ID: 22442210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of CCR5-delta32 mutation in asthmatic and non-asthmatic subjects from department of medicine, JUCM, Cracow.
    Gomulska M; Rusin G; Gwiazdak P
    Folia Med Cracov; 2014; 54(4):5-13. PubMed ID: 25891238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
    Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
    Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between chemokine receptor 5 (CCR5) δ32 mutation and pathogenesis of asthma in Iranian patients.
    Abousaidi H; Vazirinejad R; Arababadi MK; Rafatpanah H; Pourfathollah AA; Derakhshan R; Daneshmandi S; Hassanshahi G
    South Med J; 2011 Jun; 104(6):422-5. PubMed ID: 21886032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.